A case of uncommon withdrawal symptoms after a short period of spinal morphine administration

Pain

Volumn 64, Issue 3, 1996, Pages 589-591

  Devulder, Jacques ^a   Bohyn, Peter ^a   Castille, Frédéric ^a   De Laat, Martine ^a   Rolly, Georges ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chronic pain; Intrathecal morphine; Morphine withdrawal

Indexed keywords

MORPHINE;

ADULT; ARTICLE; CASE REPORT; CHRONIC PAIN; CLINICAL TRIAL; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

EID: 0029975486     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(95)00187-5     Document Type: Article

References (16)

1. Cridland, R., Sutak, M. and Jhamandas, K., Characteristics of precipitated withdrawal from spinal morphine: changes in (Met)enkephalin levels, Eur. J. Pharmacol., 203 (1991) 93-103.
2. Cruz, S.L. and Villarreal, J.E., Acute opioid dependence in the cardiovascular system of the spinal rat, J. Pharmcol. Exp. Ther., 265 (1993) 128-133.
3. Delander, G. and Takemori, A., Spinal antagonism of tolerance and dependence induced by systemically administered morphine, Eur. J. Pharmacol., 94 (1983) 35.
4. Fishbain, D , Rosomoff, H. and Rosomoff, R., Drug abuse, dependence, and addiction in chronic pain patients, Clin. J. Pain, 8 (1992) 77-85.
5. Jaffe, J., Opiates: Clinical Aspects in Substance Abuse: a Comprehensive Textbook. 2nd edn., Ch. 14, Lowin et al. (Eds.), Williams and Wilkins, Baltimore, MD, 1992, pp. 189-191.
6. Jamison, R., Anderson, K., Peeters-Asdourian, C. and Ferrante, M., Survey of opioid use in chronic nonmalignant pain patients, Reg. Anesth., 19 (1994) 225-230.
7. Krames, E., Intrathecal Infusional therapies for intractable pain: patient management guidelines, J. Pain Sympt. Manag., 8 (1993a) 36-46.
8. Krames, E., The chronic intraspinal use of opioid and local anesthetic mixtures for the relief of intractable pain: when all else fails!, Pain, 55 (1993b) 1-4.
9. Marshall, D.C., and Buccafusco, J.J., Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats, Brain. Res., 329 (1985) 131-142.
10. Maynert, E. and Klingman, G., Tolerance to morphine. Effects on catecholamines in the brain and adrenal glands, J. Pharmacol. Exp. Ther., 135 (1962) 285.
11. Milne, B., Cervenko, F., Jhamandas, K. and Sutak, M., Intrathecal clonidine: analgesia and effect on opiate withdrawal in the rat, Anesthesiology, 62 (1985) 34.
12. Paice, J., Penn, R. and Ryan, W., Altered sexual function and decreased testosterone in patients receiving intraspinal opioids J. Pain Sympt. Manag., 9 (1994) 126-131.
13. Portenoy, R., Chronic opioid therapy in nonmalignant pain J. Pain Sympt. Manag., 5 (Suppl.) (1990) 46-62.
14. Seers, K., and Clark, H., Opioid use in the treatment of chronic pain: assessment of addiction, J. Pain Sympt. Manag., 8 (1993) 257-264.
15. Ueda, H., Tamura, S., Satoh, M. and Takagi, H., Excess release of substance P from the spinal cord of mice during morphine withdrawal and involvement of the enhancement of presynaptic calcium entry, Brain Res., 425 (1987) 101.
16. Zenz, M., Strumpf, M. and Tryba, M., Long-term oral opioid therapy in patients with chronic nonmalignant pain, J. Pain Sympt. Manag., 7 (1992) 69-77.